Upon vascular injury, platelets adhere to collagen and release dense granule content to recruit more circulating platelets to an injured site. This process is initiated by signaling through glycoprotein VI (GPVI), a major platelet collagen receptor, leading to intracellular calcium mobilization and the activation of protein kinase C (PKC) isoforms. Of the 7 PKC isoforms expressed in platelets, PKCδ differentially regulates dense granule release in platelets; it positively regulates dense granule release by thrombin and negatively regulates it by collagen.1 

Schematic representation of the signaling events that are initiated on binding of collagen, convulxin, or collagen-related peptide (CRP) to platelet GPVI receptor complex leading to dense granule release.

Schematic representation of the signaling events that are initiated on binding of collagen, convulxin, or collagen-related peptide (CRP) to platelet GPVI receptor complex leading to dense granule release.

Close modal

Chari et al provide convincing evidence regarding the negative regulation of dense granule release downstream of GPVI signaling and reveal a new association of PKCδ with Lyn and SHIP1.1  Lyn is an important member of the Src tyrosine kinase family that functions downstream of GPVI, whereas SHIP1 is a lipid phosphatase that regulates PIP3 levels in platelets.2  SHIP1 associates with members of the Src family of protein kinases and is phosphorylated on Y1020, leading to its activation.3 

Activation of GPVI results in activation of Syk, which activates LAT, leading to the generation of diacylglycerol (DAG) and IP3 through activation of PLCγ. IP3 induces release of Ca2+ from intracellular stores whereas DAG activates several isoforms of PKC in a Ca2+-dependent manner, leading to dense granule release.4 

Using both pharmacologic agents and PKCδ-null murine platelets, it has been previously shown that PKCδ, which is also activated by DAG, exerts a negative effect on dense granule release induced by collagen.5,7  Here, Chari et al show that PKCδ selectively associates with tyrosine-phosphorylated SHIP1 downstream of GPVI, but not with thrombin receptors.1  This association is absent in Lyn knockout murine platelets, suggesting a role for Lyn-mediated tyrosine phosphorylation of SHIP1. Furthermore, SHIP1 tyrosine phosphorylation is diminished in PKCδ-null mice, suggesting a role for PKCδ in bringing Lyn and SHIP1 together. Most interestingly, when this ternary interaction among Lyn, SHIP1, and PKCδ fails due to the absence of any one of the members, collagen-induced dense granule release is potentiated. Thus, the tight association through phosphorylation events among Lyn, SHIP1, and PKCδ puts an embargo on dense granule release induced through GPVI signaling (outlined in the figure). As SHIP1 is known to reduce levels of PIP3, an important enhancer of platelet functions, it is possible that the negative regulation is achieved by hydrolysis of PIP3 by SHIP1 that is associated with and possibly regulated by PKCδ.

Future studies should answer some of these intriguing questions: Does PKCδ, a serine threonine kinase, phosphorylate the serine residues of SHIP1? Does the phosphorylation of serine residues of SHIP1 affect its catalytic activity? Does Lyn directly phosphorylate SHIP1 or is some other tyrosine kinase involved in this process? Does PKCδ serve as an adapter protein to bring Lyn and SHIP1 together? What is the mechanism of the association of PKCδ with SHIP1? Why does SHIP1 only associate with PKCδ downstream of GPVI? Are there other targets of PKCδ that regulate dense granule release? Thus, using a combination of biochemical, pharmacologic, and genetic approaches, Chari et al provide an intriguing avenue for further studies that will enhance our knowledge about platelet dense granule release. These insights may also aid in design and development of novel therapeutic agents for the treatment of thrombotic disorders.

Conflict-of-interest disclosure: The author declares no competing financial interests. ■

1
Chari
 
R
Kim
 
S
Murugappan
 
S
Sanjay
 
A
Daniel
 
JL
Kunapuli
 
SP
Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.
Blood
2009
114
14
3056
3063
2
Giuriato
 
S
Pesesse
 
X
Bodin
 
S
et al
SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3, 4, 5-trisphosphate levels.
Biochem J
2003
376
Pt 1
199
207
3
Crosby
 
D
Poole
 
AW
Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets.
J Biol Chem
2003
278
27
24533
24541
4
Konopatskaya
 
O
Gilio
 
K
Harper
 
MT
et al
PKCalpha regulates platelet granule secretion and thrombus formation in mice.
J Clin Invest
2009
119
2
399
407
5
Chari
 
R
Getz
 
T
Nagy
 
B
et al
Protein kinase Cδ differentially regulates platelet functional responses.
Arterioscler Thromb Vasc Biol
2009
29
5
699
705
6
Murugappan
 
S
Chari
 
R
Palli
 
VM
Jin
 
J
Kunapuli
 
SP
Differential regulation of threonine and tyrosine phosphorylations on protein kinase Cdelta by G-protein-mediated pathways in platelets.
Biochem J
2009
417
1
113
120
7
Pula
 
G
Schuh
 
K
Nakayama
 
K
Nakayama
 
KI
Walter
 
U
Poole
 
AW
PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation.
Blood
2006
108
13
4035
4044
Sign in via your Institution